BIOLASE, Inc. Provides Cash Flow Guidance for the Fourth Quarter of 2012 and Year Ended December 31, 2013
January 22, 2013 at 10:29 am EST
Share
BIOLASE, Inc. provided cash flow guidance for the fourth quarter of 2012 and year ended December 31, 2013. For the quarter, the company announced that based on preliminary unaudited financial results, the company expects to report that it generated positive cash flow from operations for fourth quarter of 2012.
Based on current plans, the company expects that it will continue to generate positive cash flow from operations for the overall year ending December 31, 2013.
BIOLASE, Inc. is a medical device company that develops, manufactures, markets and sells laser systems in dentistry and medicine. The Company's systems allow dentists, periodontists, endodontists, pediatric dentists, oral surgeons, and other dental specialists to perform a broad range of minimally invasive dental procedures, including cosmetic, restorative, and complex surgical applications. It offers two categories of laser system products: Waterlase (all-tissue) systems and diode (soft-tissue) systems. The Company's all-tissue Waterlase dental laser systems consist of its flagship Waterlase iPlus, Waterlase Express, and Waterlase MDX. Its soft tissue diode laser systems consist of the Epic X, Epic Hygiene, Epic Q, and Epic 10 diode lasers that perform soft tissue, hygiene, cosmetic procedures, teeth whitening, and provide temporary pain relief. Epic X, and Epic 10 systems feature its 940 nanometer wavelength with patented pulse technology called ComfortPulse.
BIOLASE, INC. 
